Showing: 7 - 12 of 34 RESULTS

$27M in federal funding to extend vaccine provide

HHS and the U.S. Division of Protection introduced this week that they’ll spend an extra $27.7 million to extend manufacturing of low dead-space syringes and needles, that are briefly provide because of the pandemic.

LDS syringes and needles permit suppliers to extract each dose of vaccine vial upon injection.

This will help suppliers stretch out present vaccine provide by 20%.

Different syringes have extra space between the needle and plunger when it is pushed into pores and skin, losing as much as 17% of the Moderna vaccines and 13% of the Pfizer vaccine, based on a Wall Avenue Journal report.

The syringes have been briefly provide at healthcare services since early this yr.

The federal funding will profit Retractable Applied sciences Inc., which over the previous yr has acquired over $130 million to extend the nation’s manufacturing capability by 75%. The whole allotted funding is sort of double the corporate’s

Read More

How Black ladies grapple with witnessing police violence

Consultants have observed a rise within the severity of psychological well being situations amongst Black ladies who witness police violence — just like the one who witnessed George Floyd’s homicide.

Zaria Howell, Alexa Mikhail

Initially printed by The nineteenth

In Might 2020, the world’s consideration turned to Minneapolis, the place George Floyd was killed by a police officer. After Floyd’s dying got here a summer time of protests and, almost a 12 months later, three convictions for Derek Chauvin, the previous police officer who murdered Floyd.

Someplace amid all of this chaos was Darnella Frazier, who was 17 when she captured Floyd’s closing pleas for assistance on digital camera — footage that will function major proof within the trial in opposition to Chauvin.

Frazier testified on the trial, sworn in simply days after her 18th birthday together with three different ladies.  She instructed the jury in emotional testimony that she stays

Read More

Cleveland Clinic joins scientific trial of allergic reactions to COVID-19 vaccine

Cleveland Clinic will function the one scientific web site in Ohio to take part in a nationwide multi-center scientific trial to review extreme allergic response to mRNA COVD-19 vaccines, in response to a information launch.

The Nationwide Institute of Allergy and Infectious Illnesses (NIAID), a part of the Nationwide Institutes of Well being (NIH), is main the trial to review the incidents of such anaphylactic reactions and whether or not sure danger components enhance the chance of experiencing the doubtless life-threatening allergic reactions. Present analysis recommend anaphylaxis or extreme allergic response to the mRNA vaccines (these manufactured by Pfizer or Moderna) happens in about 2.5 to five.5 folks per 1 million doses, the discharge acknowledged.

“We acknowledge that some folks could also be hesitant about getting vaccinated,” mentioned Dr. David Lang, chairman of the Division of Allergy & Immunology within the Cleveland Clinic Respiratory Institute, and a principal investigator of

Read More

Why ‘world’s pharmacy’ India is brief on photographs

Final yr, Indian Prime Minister Narendra Modi advised the United Nations his nation would make sufficient COVID-19 vaccines “to assist all humanity.” Now India is struggling to fulfill its personal home wants for the photographs amid a startling surge of infections.

Because the world’s largest maker of vaccines, India at all times was anticipated to play a pivotal function in world efforts to immunize towards COVID-19. However a combination of overconfidence, poor planning and dangerous luck has prevented that from taking place.

This is a take a look at what went flawed:

Caught off guard

Officers in India appeared to have been caught off guard by a number of issues, together with the pace at which vaccines had been permitted to be used around the globe. India like many different international locations had been working underneath the belief that vaccines would not be prepared to be used till mid-2021.


Read More

CMS will not prolong the Subsequent Era ACO Mannequin by means of 2022

CMS will not prolong the Subsequent Era ACO Mannequin by means of 2022 however will permit contributors to use for the usual monitor of its World and Skilled Direct Contracting Mannequin, the company stated in a letter to Subsequent Gens on Friday.

The American Hospital Affiliation, Nationwide Affiliation of Accountable Care Organizations and different supplier teams had lobbied the Biden administration to increase the Subsequent Gen ACO Mannequin by means of the top of subsequent 12 months. And their calls grew extra pressing after CMS’ Heart for Medicare and Medicaid Innovation introduced it could pause new purposes for its World and Skilled Direct Contracting Mannequin in April. The choice had left many direct contracting entities with no dwelling for 2022, forcing them to reevaluate their plans with out understanding what might come subsequent.

Subsequent Gens did not get the extension they’d sought, however they did get some aid when CMMI

Read More

Why are some healthcare staff refusing COVID vaccines?

“Vaccines are one of many best public well being innovations of the final century; why is it that folk are involved?” Moniz continued.

To reply that query, a College of Michigan workforce consisting of Moniz and different researchers despatched out a survey in February about vaccine hesitancy to all workers of Michigan Drugs, College of Michigan’s Ann Arbor-based well being system.

Of the 11,387 individuals who responded, the overwhelming majority have been in favor of getting the vaccine: just below 80% of the respondents mentioned that they had gotten a vaccine or have been scheduled to obtain one and 4.8% mentioned they wished to get it as quickly as attainable.

However there have been nonetheless a whole bunch of healthcare staff who have been vaccine hesitant — 954 people, or 8.4% of respondents, reported they’d not be getting the vaccine for now. And 369 individuals, or 3.2% of survey members,

Read More